Proliferative Angiopathy: A Systematic Review

Nolan J. Brown, Brian V. Lien, Jeff Ehresman, Redi Rahmani, J. Catapano, Michael T. Lawton
{"title":"Proliferative Angiopathy: A Systematic Review","authors":"Nolan J. Brown, Brian V. Lien, Jeff Ehresman, Redi Rahmani, J. Catapano, Michael T. Lawton","doi":"10.1161/svin.123.001186","DOIUrl":null,"url":null,"abstract":"\n \n First described over 4 decades ago as a diffuse form of arteriovenous malformation, cerebral proliferative angiopathy (CPA) is now categorized as a distinct vascular anomaly. Unlike arteriovenous malformation, which typically forms a well‐developed vascular nidus with feeder vessels and distinct venous outflow, CPA is the product of disorganized angiogenesis; thus, it lacks a true nidus. Its characteristic cycle of ischemia, angiogenesis, and aberrant perfusion can lead to abnormal blood flow patterns that characterize the disease. Treatment of CPA has historically relied on conservative management (antiepileptic drugs), and efforts to effectively manage this pathology have been hindered by an incomplete understanding of its natural history.\n \n \n \n A systematic search of 4 databases was performed. The following variables were extracted when present: study sample size, year of publication, age(s) of patient(s), sex, presenting signs and symptoms, neurological deficits (pre‐ and postoperative), type of intervention, average follow‐up time, and patient‐reported as well as functional outcomes at last follow‐up.\n \n \n \n Following the search and screen, 48 studies reporting 105 CPA cases remained eligible for inclusion. These studies consisted of 41 case reports, 6 case series, and 1 retrospective cohort study. The most common modality used in treatment of CPA was conservative management (53.4%). The second most common treatment modality was endovascular embolization (36.9%). The least common treatment modality was gamma knife radiosurgery, which was used in only 2 patients. Eleven patients experienced intracranial hemorrhage as a complication of CPA; 10 of the 11 patients underwent decompressive craniectomy. Finally, revascularization surgery was reportedly used in 5 patients (4.9%).\n \n \n \n Although there remains a dearth of studies reporting CPA, several clearly defined traits have been identified that characterize this pathology and distinguish it from arteriovenous malformation. Nonetheless, the verdict has not yet been reached regarding the effectiveness of surgical interventions.\n","PeriodicalId":21977,"journal":{"name":"Stroke: Vascular and Interventional Neurology","volume":"67 6","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Stroke: Vascular and Interventional Neurology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1161/svin.123.001186","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

First described over 4 decades ago as a diffuse form of arteriovenous malformation, cerebral proliferative angiopathy (CPA) is now categorized as a distinct vascular anomaly. Unlike arteriovenous malformation, which typically forms a well‐developed vascular nidus with feeder vessels and distinct venous outflow, CPA is the product of disorganized angiogenesis; thus, it lacks a true nidus. Its characteristic cycle of ischemia, angiogenesis, and aberrant perfusion can lead to abnormal blood flow patterns that characterize the disease. Treatment of CPA has historically relied on conservative management (antiepileptic drugs), and efforts to effectively manage this pathology have been hindered by an incomplete understanding of its natural history. A systematic search of 4 databases was performed. The following variables were extracted when present: study sample size, year of publication, age(s) of patient(s), sex, presenting signs and symptoms, neurological deficits (pre‐ and postoperative), type of intervention, average follow‐up time, and patient‐reported as well as functional outcomes at last follow‐up. Following the search and screen, 48 studies reporting 105 CPA cases remained eligible for inclusion. These studies consisted of 41 case reports, 6 case series, and 1 retrospective cohort study. The most common modality used in treatment of CPA was conservative management (53.4%). The second most common treatment modality was endovascular embolization (36.9%). The least common treatment modality was gamma knife radiosurgery, which was used in only 2 patients. Eleven patients experienced intracranial hemorrhage as a complication of CPA; 10 of the 11 patients underwent decompressive craniectomy. Finally, revascularization surgery was reportedly used in 5 patients (4.9%). Although there remains a dearth of studies reporting CPA, several clearly defined traits have been identified that characterize this pathology and distinguish it from arteriovenous malformation. Nonetheless, the verdict has not yet been reached regarding the effectiveness of surgical interventions.
增生性血管病:系统回顾
脑增生性血管病(CPA)在四十多年前首次被描述为一种弥漫性动静脉畸形,现在已被归类为一种独特的血管异常。动静脉畸形通常会形成一个发达的血管巢,并伴有支血管和明显的静脉流出,而 CPA 则不同,它是无序血管生成的产物,因此缺乏真正的血管巢。其特有的缺血、血管生成和异常灌注循环会导致血流模式异常,这也是本病的特征。CPA 的治疗历来依赖于保守治疗(抗癫痫药物),对其自然病史的不完全了解阻碍了有效治疗这种病变的努力。 我们对 4 个数据库进行了系统检索。如果存在以下变量,则对其进行提取:研究样本大小、发表年份、患者年龄、性别、出现的体征和症状、神经功能缺损(术前和术后)、干预类型、平均随访时间、患者报告的结果以及最后一次随访时的功能结果。 经过检索和筛选,有 48 项报告了 105 个 CPA 病例的研究仍符合纳入条件。这些研究包括 41 篇病例报告、6 篇系列病例和 1 篇回顾性队列研究。治疗 CPA 最常用的方法是保守治疗(53.4%)。其次是血管内栓塞(36.9%)。最不常用的治疗方式是伽玛刀放射外科手术,仅有2名患者采用了这种治疗方式。有 11 名患者因 CPA 并发颅内出血,其中 10 名患者接受了减压开颅手术。最后,据报道有 5 名患者(4.9%)接受了血管重建手术。 尽管报告 CPA 的研究仍然很少,但已经发现了几种明确定义的病理特征,并将其与动静脉畸形区分开来。尽管如此,关于手术干预的有效性,目前还没有定论。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信